| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in ARWR over the last quarter tilts toward selling: insiders offloaded a net 13,600 shares worth roughly $1.2M.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 3.79M | $225.78M | - | |
| COO | 547.4K | $32.59M | - | |
| Other | 227.0K | $13.51M | - | |
| CFO | 162.9K | $9.70M | - | |
| Dir | 111.5K | $6.64M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 14, 2016 | Douglas B Given66 | Director | Sell | 12,000 | $6.72 | $80,640.00 | -14.6% | |
| Aug 23, 2016 | Kenneth Allen Myszkowski68 | Chief Financial Officer | Sale+OE | 20,000 | $8.00 | $160,000.00 | -14.7% | |
| Dec 30, 2015 | Kenneth Allen Myszkowski68 | Chief Financial Officer | Sell | 23,347 | $6.13 | $143,117.11 | -21.5% | |
| Jan 5, 2015 | David L. Lewis | Chief Scientific Officer | Sale+OE | 15,000 | $8.01 | $120,103.50 | - |